CACLP - The largest IVD Expo & Conference

Roche Respiratory Panel Nabs FDA Clearance

Industry news | 05 August, 2025 | CACLP

Original from: 360dx

 

Roche on Monday announced that its Cobas Respiratory 4-flex test for SARS-CoV-2, influenza A/B, and respiratory syncytial virus has received clearance from the US Food and Drug Administration.

 

The test simultaneously detects and differentiates between the four viruses and runs on the Cobas 5800, 6800, and 8800 PCR-based systems. The assay uses Roche's new Temperature-Activated Generation of Signal (TAGS) technology and includes a digital reflex option that allows for additional results to be obtained from the same test run beyond the initial reported results, Roche said in a statement. The firm added that in the US, digital reflex testing will only be available on the Cobas 5800 system at launch. It will be added to the Cobas 6800/8800 systems with software version 2.0, which it said is in development and not available in the US. 

 

"The Cobas Respiratory 4-flex assay offers a significant technological advancement that empowers labs to address evolving respiratory testing demands now and in the future," said Roche Diagnostics North America President and CEO Brad Moore. "The expanded testing capabilities, enabled by TAGS technology, will allow labs to deliver reliable and relevant patient testing, while also optimizing healthcare resources."

 

The TAGS technology uses multiplex PCR testing combined with color, temperature, and data processing to enable the detection and differentiation of multiple targets within a single optical channel, Roche noted.

 

"Our goal for the Respiratory 4-flex is to allow labs to customize testing based on clinical needs, patient symptoms, which are often similar, and to better support a constantly shifting respiratory landscape," said Denise Heaney, chief medical partner for molecular solutions and infectious disease at Roche Diagnostics. "TAGS technology allows for the detection of more targets on a high-throughput platform, which supports diagnostic stewardship while reaching a broader patient population."

 

Source: Roche Respiratory Panel Nabs FDA Clearance

Filed under:
Press contact CACLP - The largest IVD Expo & Conference

Stay in touch with CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News, sign-up for our newsletter today.

  • Name *
  • Email *
  • Company name *
  • Country *
    CACLP - The largest IVD Expo & Conference

By subscribing our newsletter, you agree to our Privacy Policy. You can unsubscribe at anytime.

Share
Opening Countdown
0 0 0

Day(s)

0 0

Hour(s)

0 0

Min(s)

Room 1808, Cloud Nine Plaza
1118 West Yan’an Road
Shanghai, China
200052

Copyright © 2025 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )

We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy & Cookies for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

CACLP - The largest IVD Expo & Conference